Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.65 |
| ▸ | CA2 | P00918 | 3/20 | 0.65 |
| ▸ | CA7 | P43166 | 3/20 | 0.65 |
| ▸ | CA9 | Q16790 | 2/20 | 0.65 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.52 |
| ▸ | NPC1 | O15118 | 2/20 | 0.52 |
| ▸ | RAB9A | P51151 | 2/20 | 0.52 |
| ▸ | HTT | P42858 | 2/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.46 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.45 |
| ▸ | HRH1 | P35367 | 1/20 | 0.45 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6223335 | 0.88 | CA1 (0.60) | CA1CA2CA7CA9MEN1 | |
| SCHEMBL14369158 | 0.88 | CA1 (0.65) | CA1CA2CA7CA9MEN1 | |
| SCHEMBL27586591 | 0.87 | CA1 (0.59) | CA1CA2CA7CA9MEN1 | |
| SCHEMBL26783053 | 0.85 | MEN1 (0.62) | CA1CA2CA7CA9MEN1 | |
| SCHEMBL5551797 | 0.85 | MEN1 (0.62) | CA1CA2CA7CA9MEN1 | |
| SCHEMBL27586589 | 0.85 | MEN1 (0.62) | CA1CA2CA7CA9MEN1 | |
| SCHEMBL14101795 | 0.85 | CA1 (0.61) | CA1CA2CA7CA9MEN1 | |
| SCHEMBL8384593 | 0.84 | MEN1 (0.58) | CA1CA2CA7CA9MEN1 | |
| SCHEMBL13687326 | 0.84 | HTT (0.53) | CA1CA2CA7CA9MEN1 | |
| SCHEMBL8742079 | 0.82 | MEN1 (0.62) | CA1CA2CA7CA9MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1531444-A | Synthetic catalyst for selective cleavage of protein and method for selective cleavage of protein using same | ������������ʽ���� | 2004-09-22 | — | — | CN | disclosed |
| US-20020165365-A1 | Synthetic catalyst for selective cleavage of protein and method for selective cleavage of protein using the same | ARTZYME BIOTECH CORPORATION (KR) | 2002-11-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020165365-A1 | Synthetic catalyst for selective cleavage of protein and method for selective cleavage of protein using the same | CPN1, RNPEP, ANPEP | CA1 298/4885CA2 1646/4885CA7 1728/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.